As blockchain adoption moves beyond speculation and into real-world applications, one of the biggest obstacles remains ...
Two thousand two hundred twelve study patients were, on average, 63.0 years old, 69.9% of them were men, and 61.9% had a nonsquamous cell carcinoma. During the 2 years after nivolumab treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback